NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » News » Caris, Debiopharm to develop companion diagnostic to detect rare FGFR fusions » Debiopharm

Caris, Debiopharm to develop companion diagnostic to detect rare FGFR fusions

Image: Caris and Debiopharm have collaborated to develop companion diagnostic to detect rare FGFR fusions. Photo: courtesy of Michal Jarmoluk / Pixabay.

NS Medical Devices is using cookies

Image: Caris and Debiopharm have collaborated to develop companion diagnostic to detect rare FGFR fusions. Photo: courtesy of Michal Jarmoluk / Pixabay.

Related Article

Four major advances made in external radiotherapy for treating cancer

RECOMMENDED COMPANIES

MOST READ

Four major advances made in external radiotherapy for treating cancer

Vaxess timeline: The US biotech firm racing to bring its Covid-19 vaccine patch to clinical trials

Nine questions on electric manufacturing with Watlow chief system designer Andy Selvy

Top five medical device companies based in California by market cap

Bioengineered hybrid muscle fibre could be used to regenerate damaged muscle tissue

Recommended Whitepaper